Cytokinetics Balance Sheet
NASDAQ: CYTKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cytokinetics financial position
At the end of fiscal 2025, Cytokinetics reported total assets of $1.42 billion, up 1.6% from a year earlier against total liabilities of $2.08 billion. Shareholders' equity was negative at -$659.6 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $122.5 million in cash and equivalents against $287.6 million of debt, a net debt position of $165.0 million.
The current ratio (current assets divided by current liabilities) was 4.53, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Cytokinetics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 122.52M | 94.86M | 113.02M | 65.58M | 112.67M | 82.98M | 36.43M | 42.26M | 125.21M | 66.87M |
| Short-Term Investments | 759.70M | 981.16M | 501.80M | 717.00M | 358.97M | 381.07M | 188.68M | 156.47M | 143.69M | 89.38M |
| Receivables | 17.76M | 16.65M | 1.28M | 147.00K | 51.82M | 4.42M | 5.16M | 2.23M | 1.11M | 24.00K |
| Inventory | 0 | — | — | — | — | — | — | — | — | — |
| Total Current Assets | 916.98M | 1.11B | 628.05M | 795.19M | 535.67M | 474.22M | 233.75M | 207.67M | 274.30M | 158.63M |
| Property, Plant & Equipment | 79.19M | 65.81M | 68.75M | 80.45M | 73.27M | 13.35M | 4.53M | 3.20M | 3.57M | 3.64M |
| Long-Term Investments | 335.05M | 145.06M | 40.53M | 46.71M | 152.05M | 36.95M | — | — | — | — |
| Total Assets | 1.42B | 1.40B | 824.32M | 1.01B | 841.32M | 533.80M | 289.81M | 211.18M | 294.81M | 170.14M |
| Accounts Payable | 22.34M | 20.37M | 21.51M | 25.61M | 21.09M | 8.05M | 8.16M | 3.76M | 5.25M | 4.24M |
| Short-Term Debt | 41.18M | 11.52M | 10.08M | 958.00K | — | 0 | 0 | 2.61M | 0 | 2.50M |
| Total Current Liabilities | 202.45M | 179.67M | 102.68M | 84.62M | 71.86M | 31.20M | 26.02M | 22.19M | 32.44M | 33.26M |
| Long-Term Debt | 246.38M | 93.23M | 58.38M | 63.81M | 47.37M | 46.21M | 45.05M | 39.81M | 31.78M | 27.38M |
| Total Liabilities | 2.08B | 1.54B | 1.21B | 1.12B | 597.46M | 420.42M | 300.75M | 185.24M | 184.97M | 75.78M |
| Shareholders' Equity | -659.63M | -135.37M | -386.32M | -107.90M | 243.86M | 113.38M | -10.94M | 25.93M | 109.84M | 94.36M |
| Retained Earnings | -3.49B | -2.70B | -2.11B | -1.59B | -1.21B | -992.31M | -865.02M | -743.32M | -646.08M | -518.29M |
| Total Debt | 287.56M | 104.75M | 68.46M | 64.77M | 47.37M | 46.21M | 45.05M | 42.41M | 31.78M | 29.88M |
| Net Cash (Debt) | 594.66M | 971.27M | 546.36M | 717.81M | 424.27M | 417.85M | 180.06M | 156.32M | 237.11M | 126.37M |
| Shares Outstanding | 122.94M | 118.21M | 101.64M | 94.83M | 84.80M | 71.02M | 59.17M | 54.72M | 53.96M | 40.65M |
This table shows 10 annual periods of Cytokinetics's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow CYTK's reporting calendar. What is a balance sheet?